Skip to main content

    Main navigation

    • Investors
    • About
    • News
    • Contact us
    • Egoo.health
    • en
    • sv
Home

Main navigation

  • Investors
  • About
  • News
  • Contact us
  • Egoo.health
  • en
  • sv
 

Investors

+

Main navigation

Main navigation

  • News - Press releases
  • Financial Calendar
  • Financial reports
    • IPO and listning documents
  • Corporate governance
    • Articles Of Association
    • AGM and Extraordinary general meetings
      • Annual General Meeting on May 5 2022
      • Annual general meeting on 5 May 2021
      • Extraordinary Shareholders Meeting 19 November
      • Extraordinary general meeting January 2020
      • Annual General Meeting, May 20, 2020
    • Auditor
    • Nomination Committee
    • Certified adviser
  • Share information
    • Major shareholders
    • Sharecapital
    • Incentive programme
    • Dividend Policy
    • Warrants (TO)
  • Board
  • Management
  • Insiders
  • IR Contact
  • Presentations

Insiders

Qlife Holding AB complies with Article 19 of the Market Abuse Regulation (MAR). According to Article 19 of the MAR, as well as guidance from the Swedish Financial Supervisory Authority, persons in senior management (insiders) and their close associates must report changes in their holdings to the Swedish Financial Supervisory Authority. Information on insider trading in Qlife's share made by persons in leading positions can be found on Finansinspektionen's website.

Insiders:

  • Thomas Warthoe - CEO
  • Kasper Damgaard Rousøe - CFO
  • Peter Warthoe - CSO
  • Jakob Broberg Lind - Sales Director
  • Maiken Worsöe Rosenstierne - Director R&D
  • Kristina Christensen - Director QA/RA
  • John Søndergaard - Director Production
  • Mette Gross - Chairman
  • John Moll - Board member
  • Mette-Marie Harild - Board member
  • Mikael Persson - Board member
  • Ulrik Harrysson - Board member

Auditor: Olof Andersson and Jörgen Lövgren, BDO AB (Malmö)

Qlife

Qlife Holding AB
Redaregatan 48
SE-252 36 Helsingborg, Sweden
info@egoo.health

Links

  • About
  • Investors
  • Egoo.health

Qlife Holding AB is a med-tech group that strives to revolutionize the market for clinical biomarker and virus tests. By enabling tests at home as a complement to tests in healthcare, access to important health information that can contribute to better treatment and potential prevention of diseases is facilitated. On March 2, 2020, Qlife Holding completed a listing on the Nasdaq First North Growth Market, Stockholm. The company currently has about 40 employees.